ATH 0.00% 0.3¢ alterity therapeutics limited

Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial, page-108

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,248 Posts.
    lightbulb Created with Sketch. 116
    Although a year ago, it would be interesting to look at the newer advanced methods used in the open study
    https://m.youtube.com/watch?v=A2cpt4r3lvs

    I would have also expected more news, or follow up from the company given the results...hmmm
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.